Germacrane Sesquiterpenoids as a New Type of Anticardiac Fibrosis Agent Targeting Transforming Growth Factor β Type I Receptor.
Animals
Aorta
/ drug effects
Constriction
Disease Models, Animal
Dose-Response Relationship, Drug
Fibroblasts
/ drug effects
Fibrosis
/ drug therapy
Male
Molecular Structure
Rats
Rats, Sprague-Dawley
Receptors, Transforming Growth Factor beta
/ antagonists & inhibitors
Sesquiterpenes, Germacrane
/ chemistry
Structure-Activity Relationship
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
12 09 2019
12 09 2019
Historique:
pubmed:
14
8
2019
medline:
1
7
2020
entrez:
14
8
2019
Statut:
ppublish
Résumé
A germacrane sesquiterpenoid library containing 30 compounds (
Identifiants
pubmed: 31408333
doi: 10.1021/acs.jmedchem.9b00708
doi:
Substances chimiques
Receptors, Transforming Growth Factor beta
0
Sesquiterpenes, Germacrane
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM